IMD Research Round-Up: Phenylketonuria
About this episode
The episode discusses evolving treatments and research directions for Phenylketonuria (PKU).
Phenylketonuria (PKU) was one of the first inherited metabolic disorders to be recognised, but there is still plenty to discover. Silvia Radenkovic and Rodrigo Starosta are joined by Dr Cary Harding and Dr Wendy Smith to discuss evolving treatments, updated management guidelines and where PKU research is heading next. The views and opinions expressed in this podcast are those of the speakers and do not necessarily reflect those of their institutions or organisations.
More episodes of JIMD Podcasts
- Hidden Disease or Uncertain Risk? Rethinking IMD Diagnosis and Newborn Screening
- Rapamycin and Pharmacogenomics in Niemann-Pick C
- Shortcast: Clinical Outcomes in Hydroxocobalamin-Treated Patients With Early-Onset Cobalamin C Disease
- Feeding the Microbiome: Rethinking Protein and Propionate in MMA
- Shortcast: Teriparatide in Two Patients With Mucopolysaccharidosis Type IVB
Explore listener stats, chart rankings, contacts and more on the JIMD Podcasts podcast page.